Jeffrey W. Johannes

Jeffrey W. Johannes

AstraZeneca, Sweden - Södertälje / Sweden
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4401028
-
person_outline Jeffrey W. Johannes's MOST POPULAR ARTICLES
1-) Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia Nature communications 9 (1), 5341, 2018
2-) Photoredox mediated nickel catalyzed cross-coupling of thiols with aryl and heteroaryl iodides via thiyl radicals Journal of the American Chemical Society 138 (6), 1760-1763, 2016
3-) Current and future roles of artificial intelligence in medicinal chemistry synthesis Journal of medicinal chemistry 63 (16), 8667-8682, 2020
4-) Highly Chemoselective Iridium Photoredox and Nickel Catalysis for the Cross‐Coupling of Primary Aryl Amines with Aryl Halides Angewandte Chemie 128 (42), 13413-13417, 2016
5-) Preclinical characterization of AZD5305, a next-generation, highly selective PARP1 inhibitor and trapper Clinical Cancer Research 28 (21), 4724-4736, 2022